Skip to main content
. 2016 Mar 17;11(3):e0151842. doi: 10.1371/journal.pone.0151842

Fig 6. Endpoint titers.

Fig 6

Post-boosting (Week 10) antibody endpoint titers against Gag (A, C, E) and MPER (B, D, F)in serum (IgG, A and B), fecal (secretory IgA, C and D), and vaginal (secretory IgA, E and F) samples. Symbols indicate statistical significance as compared to week zero within the group evaluated by Kruskal-Wallis test and Dunn’s Multiple Comparison test: * p < 0.05, ** p < 0.01, *** p < 0.001.